Dr. Rossella Santonocito, Ph.D. in Chemical Sciences, is a Postdoctoral Research Fellow at IRCCS Rizzoli Orthopaedic Institute (IOR), Bologna, Italy, on the SAMOTHRACE project developing microfluidic fluorescent sensors for biomarker screening in orthopaedics and oncology. She earned her Ph.D. (2024, University of Catania) on “Sensor Devices for Extreme Environments,” focusing on point-of-care detection of stress biomarkers (dopamine, adrenaline, cortisol) for astronauts; M.Sc. in Chemical Sciences (110/110 cum Laude, 2021) on explosive sensors; and B.Sc. in Chemistry (2019) on CO₂ catalysts. Her research spans supramolecular chemistry, nanomaterials, and optical sensing for biomedical (salivary biomarkers, creatinine) and security applications (explosives, nerve agents, fungi), using smartphone-based arrays. She has ~25 ISI publications (h-index 9, >200 citations), 2 as corresponding author, and co-invented patent “SENSORE PER PATOGENI” (P11556IT00). Awards include 2025 Ph.D. Thesis Prize (Italian Chemical Society), Famelab 2024 winner, best presentations at SupraChemDays 2023 and AMYC BIOMED 2023. Invited speaker at ASEC25/IOCO26; organizer of MolCom'25 and biotech workshops (Chemistry as a Bridge Between Biotechnology and Magnetic Resonance).